Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Axl-targeted cancer imaging with humanized antibody h173.

Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

Mol Imaging Biol. 2014 Aug;16(4):511-8. doi: 10.1007/s11307-013-0714-z.

2.

Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft.

Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z.

Mol Pharm. 2014 Nov 3;11(11):3974-9. doi: 10.1021/mp500307t.

3.

Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.

Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

Mol Pharm. 2013 Jan 7;10(1):329-36. doi: 10.1021/mp300461b.

4.

Imaging Axl expression in pancreatic and prostate cancer xenografts.

Nimmagadda S, Pullambhatla M, Lisok A, Hu C, Maitra A, Pomper MG.

Biochem Biophys Res Commun. 2014 Jan 10;443(2):635-40. doi: 10.1016/j.bbrc.2013.12.014.

5.

Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.

Wang K, Wang K, Li W, Huang T, Li R, Wang D, Shen B, Chen X.

Acta Radiol. 2009 Dec;50(10):1095-103. doi: 10.3109/02841850903008800.

6.

Near-infrared fluorescence imaging of non-Hodgkin's lymphoma CD20 expression using Cy7-conjugated obinutuzumab.

Lin X, Zhu H, Luo Z, Hong Y, Zhang H, Liu X, Ding H, Tian H, Yang Z.

Mol Imaging Biol. 2014 Dec;16(6):877-87. doi: 10.1007/s11307-014-0742-3.

PMID:
24833041
7.

EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab.

Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

Mol Pharm. 2013 Dec 2;10(12):4527-33. doi: 10.1021/mp400354y.

8.

Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.

Qi S, Miao Z, Liu H, Xu Y, Feng Y, Cheng Z.

Bioconjug Chem. 2012 Jun 20;23(6):1149-56. doi: 10.1021/bc200596a.

PMID:
22621238
9.

Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.

Doleschel D, Mundigl O, Wessner A, Gremse F, Bachmann J, Rodriguez A, Klingmüller U, Jarsch M, Kiessling F, Lederle W.

J Nucl Med. 2012 Feb;53(2):304-11. doi: 10.2967/jnumed.111.091124.

10.

In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.

Ma W, Li G, Wang J, Yang W, Zhang Y, Conti PS, Chen K.

Amino Acids. 2014 Dec;46(12):2721-32. doi: 10.1007/s00726-014-1828-6.

PMID:
25182731
11.

Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.

Miao Z, Ren G, Liu H, Jiang L, Cheng Z.

J Biomed Opt. 2010 May-Jun;15(3):036007. doi: 10.1117/1.3432738.

PMID:
20615009
12.

Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies.

Napp J, Dullin C, Müller F, Uhland K, Petri JB, van de Locht A, Steinmetzer T, Alves F.

Int J Cancer. 2010 Oct 15;127(8):1958-74. doi: 10.1002/ijc.25405.

13.

[Preparation of magnetic near infrared fluorescent probe and targeted multimodal imaging of human mesenchymal stem cells in vitro].

Yan R, Qin J, Wang J, Liu J, Wu C, Ren L, Shan H.

Zhonghua Yi Xue Za Zhi. 2015 Jan 6;95(1):56-60. Chinese.

PMID:
25876812
14.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C.

Cancer Res. 2003 Nov 15;63(22):7870-5.

15.

In vivo tumor imaging using a near-infrared-labeled endostatin molecule.

Citrin D, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):536-41.

PMID:
14751525
16.

In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system.

Kim EM, Park EH, Cheong SJ, Lee CM, Jeong HJ, Kim DW, Lim ST, Sohn MH.

Bioconjug Chem. 2009 Jul;20(7):1299-306. doi: 10.1021/bc8005539.

PMID:
19534520
17.

RGD-human serum albumin conjugates as efficient tumor targeting probes.

Chen K, Xie J, Chen X.

Mol Imaging. 2009 Mar-Apr;8(2):65-73.

PMID:
19397852
18.

In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence.

Rosenthal EL, Kulbersh BD, Duncan RD, Zhang W, Magnuson JS, Carroll WR, Zinn K.

Laryngoscope. 2006 Sep;116(9):1636-41.

PMID:
16954995
19.

Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.

Wu J, Ma R, Cao H, Wang Z, Jing C, Sun Y, Zhang Y, Yang Z, Hoffman RM, Tang J.

Anticancer Res. 2013 Feb;33(2):419-24.

PMID:
23393332
20.

Activation of AXL and antitumor effects of a monoclonal antibody to AXL in lung adenocarcinoma.

Iida S, Miki Y, Suzuki T, Mori K, Saito M, Niikawa H, Kondo T, Yamada-Okabe H, Sasano H.

Anticancer Res. 2014 Apr;34(4):1821-7.

PMID:
24692715
Items per page

Supplemental Content

Support Center